Item 5. Other Information
Item 5 . Other Information.
On January 10, 2024 , David M. Chacko , M.D., our Chief Financial Officer and Chief Business Officer , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 260,000 shares of our common stock until December 31, 2025 . During the three months ended March 31, 2024 , no other officers (as defined in Rule 16a–1(f)) or directors adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each such term is defined in Item 408 of Regulation S-K.
31
Item 6. Exhibits.
Exhibit
Number
Exhibit Description
Incorporated by Reference
Filed Herewith
Form
Date
Number
3.1
Amended and Restated Certificate of Incorporation of Erasca, Inc.
8-K
7/20/2021
3.1
3.2
Amended and Restated Bylaws of Erasca, Inc.
8-K
7/20/2021
3.2
4.1
Specimen stock certificate evidencing the shares of common stock
S-1
6/25/2021
4.1
4.2
Amended and Restated Stockholders Agreement, dated April 15, 2020, by and among the Registrant and certain of its stockholders
S-1
6/25/2021
4.2
10.1
Stock Purchase Agreement, dated March 27, 2024, by and between Erasca, Inc. and each of the purchasers party thereto
8-K
3/28/2024
10.1
31.1
Certification of Chief Executive Officer of Erasca, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X
31.2
Certification of Chief Financial Officer of Erasca, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X
32.1*
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X
32.2*
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X
101.INS
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
X
101.SCH
Inline XBRL Taxonomy Extension Schema Document
X
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
X
* This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
32
SIG NATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Erasca, Inc.
Date: May 8, 2024
By:
/s/ Jonathan E. Lim, M.D.
Jonathan E. Lim, M.D.
Chairman, Chief Executive Officer and Co-Founder
(Principal Executive Officer)
Date: May 8, 2024
By:
/s/ David M. Chacko, M.D.
David M. Chacko, M.D.
Chief Financial Officer and Chief Business Officer
(Principal Financial and Accounting Officer)
33
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.